X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA FDC LTD. NATCO PHARMA/
FDC LTD.
 
P/E (TTM) x 32.8 17.2 191.3% View Chart
P/BV x 16.7 3.6 467.1% View Chart
Dividend Yield % 0.7 1.3 51.8%  

Financials

 NATCO PHARMA   FDC LTD.
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
FDC LTD.
Mar-14
NATCO PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs877144 611.1%   
Low Rs42479 536.1%   
Sales per share (Unadj.) Rs223.447.6 469.7%  
Earnings per share (Unadj.) Rs31.17.6 408.3%  
Cash flow per share (Unadj.) Rs40.39.0 447.0%  
Dividends per share (Unadj.) Rs5.002.25 222.2%  
Dividend yield (eoy) %0.82.0 38.0%  
Book value per share (Unadj.) Rs219.547.5 461.8%  
Shares outstanding (eoy) m33.07177.83 18.6%   
Bonus/Rights/Conversions PABB-  
Price / Sales ratio x2.92.3 124.4%   
Avg P/E ratio x20.914.6 143.2%  
P/CF ratio (eoy) x16.112.3 130.8%  
Price / Book Value ratio x3.02.3 126.6%  
Dividend payout %16.129.6 54.4%   
Avg Mkt Cap Rs m21,50419,784 108.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,1281,221 92.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m7,3898,459 87.4%  
Other income Rs m167394 42.5%   
Total revenues Rs m7,5568,852 85.4%   
Gross profit Rs m1,7932,070 86.6%  
Depreciation Rs m304249 122.2%   
Interest Rs m36631 1,180.9%   
Profit before tax Rs m1,2902,184 59.1%   
Minority Interest Rs m460-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m309606 51.0%   
Profit after tax Rs m1,0271,353 75.9%  
Gross profit margin %24.324.5 99.2%  
Effective tax rate %23.927.7 86.3%   
Net profit margin %13.916.0 86.9%  
BALANCE SHEET DATA
Current assets Rs m3,6814,355 84.5%   
Current liabilities Rs m3,1231,792 174.3%   
Net working cap to sales %7.630.3 24.9%  
Current ratio x1.22.4 48.5%  
Inventory Days Days8944 201.3%  
Debtors Days Days5925 237.9%  
Net fixed assets Rs m7,6853,025 254.1%   
Share capital Rs m331179 185.2%   
"Free" reserves Rs m6,6708,243 80.9%   
Net worth Rs m7,2598,453 85.9%   
Long term debt Rs m95511 8,924.3%   
Total assets Rs m11,95710,557 113.3%  
Interest coverage x4.571.4 6.3%   
Debt to equity ratio x0.10 10,392.5%  
Sales to assets ratio x0.60.8 77.1%   
Return on assets %11.713.1 88.9%  
Return on equity %14.216.0 88.4%  
Return on capital %20.723.5 88.2%  
Exports to sales %39.413.3 295.7%   
Imports to sales %5.73.3 170.5%   
Exports (fob) Rs m2,9081,126 258.3%   
Imports (cif) Rs m421283 148.9%   
Fx inflow Rs m3,4451,146 300.6%   
Fx outflow Rs m703355 197.8%   
Net fx Rs m2,743791 346.8%   
CASH FLOW
From Operations Rs m1,4401,485 97.0%  
From Investments Rs m-1,089-620 175.8%  
From Financial Activity Rs m-353-753 46.9%  
Net Cashflow Rs m-1113 -1.3%  

Share Holding

Indian Promoters % 52.0 68.9 75.5%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 4.7 166.8%  
FIIs % 16.6 7.5 221.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 19.0 136.8%  
Shareholders   25,395 23,730 107.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   STRIDES SHASUN LTD  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare NATCO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 21, 2017 02:17 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - ALKEM LABORATORIES COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS